Symbol="BVXV"
AssetType="Common Stock"
Name="BiondVax Pharmaceuticals Ltd ADR"
Description="BiondVax Pharmaceuticals Ltd., a development-stage biopharmaceutical company, focuses on developing, manufacturing and marketing products for the prevention and treatment of infectious and related diseases in Israel. The company is headquartered in Jerusalem, Israel."
CIK="1611747"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="JERUSALEM BIOPARK, 2ND FLOOR, HADASSAH EIN KEREM CAMPUS, JERUSALEM, IL"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="4565200"
EBITDA="-11066000"
PERatio="None"
PEGRatio="0"
BookValue="-1.465"
DividendPerShare="0"
DividendYield="0"
EPS="-4.06"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.274"
ReturnOnEquityTTM="-56.02"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-4.06"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="39"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="7.48"
EVToRevenue="-"
EVToEBITDA="-2.067"
Beta="2.383"
num_52WeekHigh="12.9"
num_52WeekLow="1.29"
num_50DayMovingAverage="1.645"
num_200DayMovingAverage="4.098"
SharesOutstanding="3284100"
DividendDate="None"
ExDividendDate="None"
symbol="BVXV"
open="1.42"
high="1.45"
low="1.39"
price="1.41"
volume="27962.00"
latest_trading_day="2023-07-10"
previous_close="1.38"
change="0.03"
change_percent="2.1739%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="89"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="11"
Volume_recent_avg="110507"
Change_recent_avg="-0.02"
Delta_recent_avg="0.13"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="-0.97"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="11"
Aroon_momentum_negative="89"
image_negative_thumbnail_id_1="1149"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0182.jpeg"
image_negative_thumbnail_id_2="100"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0076.jpeg"
image_neutral_thumbnail_id_1="585"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0014.jpeg"
image_neutral_thumbnail_id_2="566"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0033.jpeg"
image_positive_thumbnail_id_1="682"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0026.jpeg"
image_positive_thumbnail_id_2="675"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0033.jpeg"
image_professor_thumbnail_id_1="1190"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
image_professor_thumbnail_id_2="1184"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
